Medinet News

Medinet: (Changes in disclosure matters) Changes in the planned expenditure period relating to the issuance of stock acquisition rights through third-party allotment

Sep 27 04:00 ET

Medinet: Notice regarding mass exercise and completion of exercise of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment

Sep 11 03:00 ET

Medinet: Strategic partnership agreement signed with AGC for cell therapy CDMO business

Sep 10 22:00 ET

Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third-party allotment

Sep 2 02:00 ET

Medinet: Announcements of individual stocks regarding the recognition of non-operating revenue.

Aug 9 02:00 ET

Medinet: Overview of Q3 2024 financial results.

Aug 9 02:00 ET

Medinet: Third quarter financial report for the September 2024 period (Japanese standard) (non-consolidated)

Aug 9 02:00 ET

Medinet: Started manufacturing outsourcing for a new specified cell processed product ("S-DSC") related to hair regeneration.

Aug 8 02:00 ET

Medinet: (Progress of disclosure matters) Taiwanese regulatory authorities have approved the provision of γδT cell therapy at new medical institutions (progress of licensing agreement with Medigen Biotechnology Corp.)

Jul 8 02:00 ET

Medinet: Financial results briefing materials for the 2nd quarter of the fiscal year ending 2024/9

May 30 02:00 ET

Medinet: Confirmation letter

May 14 02:02 ET

Medinet: Quarterly Report - 29th Quarter 2nd Quarter (2024/01/01 to 2024/03/31)

May 14 02:00 ET

Medinet: Notice Concerning the Recording of Non-Operating Income and Non-Operating Expenses

May 10 02:00 ET

Medinet: Summary of financial results for the 2nd quarter of 2024

May 10 02:00 ET

Medinet: Summary of financial results for the 2nd quarter of the fiscal year ending September 2024 [Japanese GAAP] (unconsolidated)

May 10 02:00 ET

Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third-party allotment

May 1 02:00 ET

Medinet: Change Report (Stock Certificates Eligible for Special Provisions, etc.)

Apr 26 02:32 ET

Medinet: (Progress of disclosure matters) Taiwan regulatory authorities approve provision of gamma-delta T cell therapy at new medical institutions

Apr 1 02:15 ET

Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment

Apr 1 02:00 ET

Medinet: (Changes in disclosure matters) Changes in the use of funds and planned expenditure periods relating to the issuance of stock acquisition rights through third-party allotment

Mar 29 03:00 ET